STAT-Dx, a company specialising in the development of advanced molecular diagnostic systems, announces that it has completed CE-IVD marking for DiagCORE®, its fully-integrated Syndromic Testing System. STAT-Dx anticipates the full commercial launch of the DiagCORE® system in Q2 2018 with an initial focus on the European market. 

Clinical data from the evaluation studies will be presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases conference which will take place on 21st to 24th April in Madrid.

STAT-Dx won the 2017 Biosuccess award of CataloniaBio.

More information is available on STAT-Dx website.